Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Decamethonium iodide
- IUPAC name
- trimethyl-[10-(trimethylazaniumyl)decyl]azanium diiodide
- Molecular formula
- C16H38I2N2
- Molecular weight
- 512.30 g/mol
- Exact mass
- 512.11244 Da
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- EPA DTXSID:DTXSID90931293
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Decamethonium
Decamethonium is a quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents. It has a role as a nicotinic acetylcholine receptor agonist and a muscle relaxant. It derives from a hydride of a decane. — ChEBI
- IUPAC name
- trimethyl-[10-(trimethylazaniumyl)decyl]azanium
- Molecular formula
- C16H38N2+2
- Molecular weight
- 258.49 g/mol
- Exact mass
- 258.303499221 Da
- XLogP3
- 3.9
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 0
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:41934
- ChEMBL:CHEMBL1190
- EPA DTXSID:DTXSID5048394
- PubMed:22151973
- PubMed:21945623
- PubMed:21936897
- PubMed:21915373
- PubMed:21728178
- PubMed:21698929
- PubMed:21687772
- PubMed:21660097
- PubMed:21387029
- PubMed:21386908
- PubMed:21251245
- PubMed:20550720
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Decamethonium chloride
- IUPAC name
- trimethyl-[10-(trimethylazaniumyl)decyl]azanium dichloride
- Molecular formula
- C16H38Cl2N2
- Molecular weight
- 329.4 g/mol
- Exact mass
- 328.2412046 Da
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
7 more reported names
External database identifiers
- EPA DTXSID:DTXSID10953871
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Decamethonium dibromide
Crystals derived from methanol and acetone. (NTP, 1992) — CAMEO Chemicals
- IUPAC name
- trimethyl-[10-(trimethylazaniumyl)decyl]azanium dibromide
- Molecular formula
- C16H38Br2N2
- Molecular weight
- 418.3 g/mol
- Exact mass
- 418.13812 Da
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEMBL:CHEMBL1134
- EPA DTXSID:DTXSID2022886
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
Regulatory information
Key data
Related records for Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparat…
Pemoline (INN) and its salts
(2-Isopropylpent-4-enoyl)urea (apronalide)
Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations)
alpha-Santonin [(3S,5aR,9bS)-3,3a,4,5,5a,9b-hexahydro-3,5a,9-trimethylnaphto[1,2-b]furan-2,8-dione]
Hyoscyamine, its salts and derivatives
Lobelia inflata L. and its galenical preparations
Nitroxoline (INN) and its salts
What Annex II means for Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
This page summarizes one Annex II record for Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II